| UBS Group, 7% perp., USD (USH42097FA09) |
| UBS Group, 7.125% perp., USD (USH42097FB81) |
| UBS Group, 7% perp., USD (CH0271428333) |
| UBS Group, 3.25% 2apr2026, EUR (20) (CH0537261858) |
| Gunvor Group, 6.25% 30sep2026, USD (XS2362619053) |
| UBS Group, 3.25% 2apr2026, EUR (20) (CH0537261858) |
| Gunvor Group, 6.25% 30sep2026, USD (XS2362619053) |
| VistaJet Holding, 6.375% 1feb2030, USD (USX9814HAC70) |
| VistaJet Holding, 6.375% 1feb2030, USD (USX9814HAC70) |
| Roche Holding AG, 7% 1mar2039, USD (USU75000AN65) |
| Nestle S.A., 1.75% 2nov2037, EUR (94) (XS1707075245) |
| Oriflame Investment Holding, 5.125% 4may2026, USD (USG67744AA34) |
| Oriflame Investment Holding, 5.125% 4may2026, USD (USG67744AA34) |
| Credit Suisse Group AG, 7.5% perp., USD (1) (XS0989394589) |
| Transocean Ltd, 11.5% 30jan2027, USD (USG90073AG56) |
| Transocean Ltd, 11.5% 30jan2027, USD (USG90073AG56) |
| UBS Group, 4.375% perp., USD (USH42097CB19) |
| UBS Group, 4.375% perp., USD (USH42097CB19) |
| Banque Cantonale de Geneve, 3.414% 27mar2030, EUR (CH1433226292) |
| Transocean Ltd, 7.5% 15apr2031, USD (US893830AF64) |
| Alcon, 2.75% 23sep2026, USD (USU01386AA60) |
| gategroup, 3% 28feb2027, CHF (CH0353945394) |
| Julius Baer Group, 7.5% perp., USD (CH1421969317) |
| Swiss Re, 5.75% 15aug2050, USD (2015-02) (XS1261170515) |
| UBS (London Branch), 0.1% 13nov2029, USD (Structured) (XS2066744660) |
| Credit Suisse Group AG, 7.25% perp., USD (USH3698DBZ62) |
| Credit Suisse Group AG, 4.5% perp., USD (USH3698DDD33) |
| Julius Baer Group, 6.875% perp., USD (XS2468403428) |
| Credit Suisse Group AG, 4.5% perp., USD (USH3698DDD33) |
| Julius Baer Group, 6.875% perp., USD (XS2468403428) |
| Zurich Insurance Company, 5.5% 23apr2055, USD (XS2924856896) |
| Transocean Ltd, 6.8% 15mar2038, USD (US893830AT68) |
| UBS Group, 6.875% perp., USD (CH0286864027) |
| Credit Suisse (London Branch), 0.25% 1sep2028, EUR (116) (XS2381671671) |
| Credit Suisse (London Branch), 0.25% 1sep2028, EUR (116) (XS2381671671) |
| Transocean Ltd, 9.35% 15dec2041, USD (US893830AZ29) |
| UBS Group, 3.75% 26mar2025, USD (US902613AX64) |
| Novartis, 4.4% 6may2044, USD (US66989HAH12) |
| EFG International, 5.5% perp., USD (CH0593093229) |
| UBS Group, 4.875% perp., USD (USH42097CS44) |
| EFG International, 5.5% perp., USD (CH0593093229) |
| UBS Group, 4.875% perp., USD (USH42097CS44) |
| UBS, 2.95% 9apr2025, USD (US22550L2C42) |
| Lithium Argentina, 1.75% 15jan2027, USD (Conv.) (US53680QAB41) |
| UBS, 2.95% 9apr2025, USD (US22550L2C42) |
| Lithium Argentina, 1.75% 15jan2027, USD (Conv.) (US53680QAB41) |
| UBS (Jersey Branch), 8.75% 18dec2025, GBP (XS0062270581) |
| UBS Group, 4.282% 9jan2028, USD (002) (USH3698DAR55) |
| Zurich Cantonal Bank, 3.6% perp., CHF (CH0361532945) |
| UBS Group, 4.194% 1apr2031, USD (009) (USH3698DCW23) |
| UBS Group, 5.125% perp., USD (CH0558521263) |
| UBS Group, 4.194% 1apr2031, USD (009) (USH3698DCW23) |
| UBS Group, 5.125% perp., USD (CH0558521263) |
| MSC Cruises, 3% 14jul2023, CHF (CH0370943562) |
| Swiss Re, 4.625% perp., USD (2017-4) (XS1640851983) |
| SIG Group AG, 2.125% 18jun2025, EUR (XS2189594315) |
| Zurich Insurance Company, 3% 19apr2051, USD (XS2283177561) |
| SIG Group AG, 2.125% 18jun2025, EUR (XS2189594315) |
| Zurich Insurance Company, 3% 19apr2051, USD (XS2283177561) |
| UBS Group, 2.875% 12feb2030, EUR (CH1414003454) |
| Amrize AG, 4.7% 7apr2028, USD (USU4335PAB59) |
| UBS Group, 4.55% 17apr2026, USD (US902613BB36) |
| UBS Group, 1.875% 3nov2029, GBP (CH1142231708) |
| UBS Group, 1.875% 3nov2029, GBP (CH1142231708) |
| Glencore International AG, 4% 16apr2025, USD (XS1218432349) |
| Zurich Insurance Company, 5.625% 24jun2046, USD (2016-01) (XS1385999492) |
| UBS Group, 4.253% 23mar2028, USD (USH4209UAC02) |
| Idorsia, 2.125% 4aug2028, CHF (Conv.) (CH1128004079) |
| Idorsia, 2.125% 4aug2028, CHF (Conv.) (CH1128004079) |
| Galderma, 3.5% 20mar2030, EUR (XS3025205850) |
| Glencore International AG, 5.186% 1apr2030, USD (USU37818BV90) |
| Rothschilds Continuation Holdings, 9% perp., GBP (XS0048662232) |
| UBS, 5.125% 15may2024, USD (CH0244100266) |
| UBS Group, 4.125% 15apr2026, USD (USG91703AK72) |
| LEONTEQ SECURITIES, 0% perp., USD (Structured) (CH0518341745) |
| LEONTEQ SECURITIES, 0% perp., USD (Structured) (CH0518341745) |
| Zurich Insurance Company, 3.5% 1oct2046, EUR (2016-01) (XS1418788755) |
| Glencore International AG, 4% 27mar2027, USD (USU37818AR97) |
| UBS Group, 4.85% perp., SGD (CH0495570928) |
| Credit Suisse Group AG, 5.25% perp., USD (USH3698DDA93) |
| Dufry Financial Services, 3.375% 15apr2028, EUR (XS2333564503) |
| Credit Suisse Group AG, 5.25% perp., USD (USH3698DDA93) |
| Dufry Financial Services, 3.375% 15apr2028, EUR (XS2333564503) |
| Petroplus Holdings, 6.75% 1may2014, USD (USG7053RAA26) |
| VistaJet Holding, 10.5% 1jun2024, USD (USX9814HAA15) |
| Swiss Re, 4.25% perp., USD (XS2049422343) |
| Glencore International AG, 3.875% 27apr2051, USD (USU37786AD91) |
| UBS Group, 0.25% 3nov2026, EUR (46) (CH1142231682) |
| Glencore International AG, 3.875% 27apr2051, USD (USU37786AD91) |
| UBS Group, 0.25% 3nov2026, EUR (46) (CH1142231682) |
| Rothschilds Continuation Holdings, FRN perp., EUR (XS0197703118) |
| UBS Group, 7.125% perp., USD (CH0271428317) |
| Aryzta, 4% perp., CHF (CH0200044813) |
| UBS Group, 4.875% 15may2045, USD (US902613AY48) |
| UBS Group, 3% perp., CHF (CH0506668869) |
| Glencore International AG, 2.5% 1sep2030, USD (USU37818AX65) |
| Oriflame Investment Holding, FRN 4may2026, EUR (XS2337349265) |
| Nestle S.A., 1.625% 15jul2026, CHF (A) (CH1194355108) |
| UBS Group, 3% perp., CHF (CH0506668869) |
| Glencore International AG, 2.5% 1sep2030, USD (USU37818AX65) |
Tahvil tarayıcı
